Founder of a Groundbreaking Malign Melanoma Treatment Becomes Doctor Honoris Causa at Ch ****************************************************************************************** * Founder of a Groundbreaking Malign Melanoma Treatment Becomes Doctor Honoris Causa at Ch ****************************************************************************************** 2. 6. 2011, By: P.K., Section: i-Forum informs, Translation: Jaroslav Švelch On June 2, Professor Patrick Anthony Riley, a world-renowned expert in pigment cell resear cancerous skin diseases, received the title of Doctor Honoris Causa in the historical buil Karolinum. The honorary title of the doctor of medicine was handed to him by his long-term and collaborator Professor Jan Borovanský. Professor Riley’s experiments had led up to the clinical testing of 4- hydroxyanisole that becoming more widespread every year. “Pigment cells can transform amino acids into quinone an assumption that if we offer suitable substrates to the tyrosinase enzyme that can creat “Professor Riley’s main achievement is the introduction of the new type of treatment. That milimeter and is not removed in time, the prognosis is very unfavourable,” noted Professor Professor Riley has repeatedly taken part in the Czech scientific conferences in biochemis dermatology and is a member of the international editorial board of the Folia Biologica jo by the Charles University 1st Faculty of Medicine. Commenting on his recent collaboration collegues, he said: “The first international monograph on melanosomes is coming out this J Wiley/Blackwell. Professor Borovanský and I have put together a team of authors and I beli going to be a success at this September’s congress in Bordeaux.” Professor Riley has collaborated with today’s Institute of Biochemistry and Experimental O and provided with them with chemicals that were unavailable in the country. It was mainly centers in the field of melanins, melanosomes and malign melanomas. Prof. P.A. Riley [ URL "http://iforum.cuni.cz/IFORUM-11089.html"] , professor emeritus of graduating in 1960. He joined the Department of Dermatological Histopathology at UCHMS as scientific career), he demonstrated the distinct lineage of Langerhans cells and melanocyt From 1966 he worked in the Department of Pathological Chemistry, UCHMS, (which over the ye Pathology in 1984. The scientific community recognises prof. Riley as a world expert and father of metabolica to unfavourable pharmacokinetics, the search for further cytotoxic tyrosine analogues has significant publications dealing with quinones. This joint work generated novel data which Prof Riley is co-founder (and former Secretary) of the European Society for Pigment Cell R Address to the Assembled Faculties of Charles University, Prague [ URL "http://iforum.cuni IFORUM-11115.html"]